EUNICE SAFOAH ASOMANING
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- DANIELSON, CT
- NPI
- 1962758508
- Received
- $8,045 in 422 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 65 | $1,039 |
| 2024 | General payment | 105 | $2,015 |
| 2023 | General payment | 96 | $1,850 |
| 2022 | General payment | 60 | $1,356 |
| 2021 | General payment | 52 | $999 |
| 2020 | General payment | 41 | $742 |
| 2019 | General payment | 3 | $41 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 419 | $8,028 |
| Education | 3 | $17 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-09 | Braeburn Inc. | $19 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-12-05 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-01 | GlaxoSmithKline, LLC. | $28 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-11-25 | Braeburn Inc. | $22 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-11-24 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-11-24 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-11-18 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-14 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-11-12 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-10 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-17 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-10-16 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-11 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-06 | Braeburn Inc. | $21 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-10-04 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-24 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-22 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-09-18 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-15 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-09-03 | Vanda Pharmaceuticals Inc. | $25 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-12 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-11 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-08-08 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-08-04 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-01 | Viatris Specialty LLC | $17 | Food and Beverage | In-kind items and services | YUPELRI Drug, Anticholinergics, Inhaled | 2025 | |
| 2025-07-22 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-14 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-06-30 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-25 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-06-13 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-06-11 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-09 | Vanda Pharmaceuticals Inc. | $25 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-06-04 | Novo Nordisk Inc | $9 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-05-29 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-05-23 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | Repatha Biological, Cardiovascular | 2025 | |
| 2025-05-21 | Vanda Pharmaceuticals Inc. | $25 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-05-16 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-06 | Phathom Pharmaceuticals, Inc. | $18 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-04-30 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-30 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-04-25 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-22 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-04-18 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-04-14 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-11 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-04-04 | Actelion Pharmaceuticals US, Inc. | $24 | Food and Beverage | In-kind items and services | OPSUMIT Drug, Cardiology | 2025 | |
| 2025-04-02 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-03-26 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-03-20 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-03-18 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-03-10 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-02-28 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-02-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-02-07 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-01-31 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-24 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-01-24 | Novo Nordisk Inc | $8 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-01-10 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-01-06 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-03 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2024-12-20 | Corcept Therapeutics | $20 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-12-13 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-12-09 | Astellas Pharma US Inc | $16 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-11-15 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-11-04 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-10-29 | Lilly USA, LLC | $24 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-10-23 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-21 | Currax Pharmaceuticals LLC | $14 | Food and Beverage | In-kind items and services | CONTRAVE Drug, Obesity | 2024 | |
| 2024-10-18 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-10-08 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-10-04 | Astellas Pharma US Inc | $32 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-10-03 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-01 | Novo Nordisk Inc | $8 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-23 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-09-16 | Corcept Therapeutics | $46 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-09-13 | Boehringer Ingelheim Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | TRADJENTA Drug, DIABETES | 2024 | |
| 2024-09-11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-09-05 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-09-04 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2024 | |
| 2024-08-28 | Novartis Pharmaceuticals Corporation | $26 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-08-23 | Indivior Inc. | $22 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2024 | |
| 2024-08-15 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-08-12 | AstraZeneca Pharmaceuticals LP | $25 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-08-12 | AstraZeneca Pharmaceuticals LP | $0 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-08-09 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-08-07 | Astellas Pharma US Inc | $20 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-08-05 | Novo Nordisk Inc | $21 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-08-02 | Merck Sharp & Dohme LLC | $19 | Food and Beverage | In-kind items and services | GARDASIL Biological, VACCINE | 2024 | |
| 2024-08-01 | Lilly USA, LLC | $27 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-07-31 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-24 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-07-24 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-24 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-24 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-07-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | TRADJENTA Drug, DIABETES | 2024 | |
| 2024-07-15 | Lundbeck LLC | $24 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-07-12 | Merck Sharp & Dohme LLC | $15 | Food and Beverage | In-kind items and services | GARDASIL Biological, VACCINE | 2024 | |
| 2024-07-07 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | AREXVY Drug, RESPIRATORY | 2024 | |
| 2024-07-03 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-01 | Actelion Pharmaceuticals US, Inc. | $28 | Food and Beverage | In-kind items and services | OPSUMIT Drug, Cardiology | 2024 | |
| 2024-06-29 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-06-28 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-06-19 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-06-17 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-06-10 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-07 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-06-06 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-06-06 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-06-05 | Astellas Pharma US Inc | $27 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-06-03 | Lilly USA, LLC | $28 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-06-03 | Actelion Pharmaceuticals US, Inc. | $25 | Food and Beverage | In-kind items and services | OPSUMIT Drug, Cardiology | 2024 | |
| 2024-05-22 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-14 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-05-09 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-06 | Merck Sharp & Dohme LLC | $13 | Food and Beverage | In-kind items and services | GARDASIL Biological, VACCINE | 2024 | |
| 2024-05-01 | Otsuka America Pharmaceutical, Inc. | $29 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-05-01 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-04-24 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-22 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-04-19 | GlaxoSmithKline, LLC. | $21 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-04-17 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-04-17 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-04-17 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-15 | Astellas Pharma US Inc | $20 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-04-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-12 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-04-10 | Corcept Therapeutics | $27 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-04-08 | Novo Nordisk Inc | $9 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-04-05 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-04-05 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-04-05 | Otsuka America Pharmaceutical, Inc. | $1 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-04-04 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-04-01 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-03-29 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-03-28 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-25 | AstraZeneca Pharmaceuticals LP | $26 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-22 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-20 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-03-15 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-03-15 | Otsuka America Pharmaceutical, Inc. | $1 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-03-13 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-03-12 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-03-12 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-02-27 | Cranial Technologies, Inc | $17 | Food and Beverage | Cash or cash equivalent | Doc Band Device, Cranial Orthotic | 2024 | |
| 2024-02-23 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-02-21 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-02-21 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-20 | Corcept Therapeutics | $21 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-02-16 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-02-09 | GlaxoSmithKline, LLC. | $26 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-02-07 | Astellas Pharma US Inc | $18 | Food and Beverage | In-kind items and services | Myrbetriq Drug, Urology | 2024 | |
| 2024-02-02 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-02-01 | GlaxoSmithKline, LLC. | $26 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-01-31 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-01-31 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-30 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-01-29 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-01-26 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-01-24 | Lilly USA, LLC | $23 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-01-22 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-01-19 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-01-11 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-01-10 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-08 | Novartis Pharmaceuticals Corporation | $28 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-01-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2023-12-18 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-12-15 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-12-13 | Corcept Therapeutics | $23 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2023 | |
| 2023-12-12 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-12-11 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-06 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-30 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-11-29 | Novartis Pharmaceuticals Corporation | $26 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-11-29 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-11-27 | Novo Nordisk Inc | $21 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-11-15 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2023 | |
| 2023-11-13 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2023 | |
| 2023-11-08 | GlaxoSmithKline, LLC. | $26 | Food and Beverage | In-kind items and services | SHINGRIX Biological, VACCINES | 2023 | |
| 2023-11-06 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-06 | Cranial Technologies, Inc | $14 | Food and Beverage | Cash or cash equivalent | Doc Band Device, Cranial Orthotic | 2023 | |
| 2023-11-03 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-11-01 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $11 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-10-30 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2023 | |
| 2023-10-27 | Novartis Pharmaceuticals Corporation | $14 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-10-23 | PFIZER INC. | $21 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2023 | |
| 2023-10-20 | GlaxoSmithKline, LLC. | $26 | Food and Beverage | In-kind items and services | AREXVY Drug, RESPIRATORY | 2023 | |
| 2023-10-18 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-16 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-10-13 | Corcept Therapeutics | $23 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2023 | |
| 2023-10-12 | GlaxoSmithKline, LLC. | $31 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-10-11 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-10-06 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-04 | Boehringer Ingelheim Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-09-29 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2023 | |
| 2023-09-28 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 |
The latest 200 records of 422.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Danielson, CT, county Northeastern Connecticut Planning Region, CT, state Connecticut; placed by its city name.
| Measure | Place (city or town) Danielson, CT | County Northeastern Connecticut Planning Region, CT | State Connecticut |
|---|---|---|---|
| Population B01003 | 4,209 | 96,312 | 3,624,508 |
| Population, 2020 census P1 | 4,155 | - | 3,605,944 |
| Median age B01002 | 34.5 | 44.1 | 41.1 |
| Under 18 B01001 | 18.9% | 18.4% | 20.2% |
| 65 and over B01001 | 13.6% | 19.8% | 18.5% |
| Households B11001 | 1,866 | 39,412 | 1,434,007 |
| Foreign born B05002 | 5.5% | 4.4% | 15.7% |
| Median household income B19013 | $64,050 | $90,589 | $95,781 |
| Median family income B19113 | $81,861 | $107,164 | $122,706 |
| Per capita income B19301 | $34,315 | $47,072 | $55,915 |
| Poverty rate B17001 | 21.1% | 7.5% | 10.0% |
| Unemployment rate B23025 | 17.1% | 6.0% | 5.6% |
| Civilian labor force B23025 | 2,729 | 53,213 | 1,959,490 |
| Mean commute (minutes) B08013 | 28.4 | 29.0 | 26.5 |
| Bachelor's degree or higher B15003 | 11.5% | 26.1% | 42.5% |
| Housing units B25001 | 1,967 | 41,736 | 1,541,822 |
| Owner-occupied B25003 | 53.0% | 77.3% | 66.5% |
| Renters B25003 | 47.0% | 22.7% | 33.5% |
| Median home value B25077 | $224,600 | $307,600 | $366,900 |
| Median gross rent B25064 | $1,235 | $1,155 | $1,488 |
| White, not Hispanic B03002 | 73.8% | 86.3% | 61.9% |
| Black B03002 | 8.0% | 1.4% | 9.8% |
| Hispanic or Latino B03002 | 12.2% | 5.2% | 18.3% |
| Asian B03002 | 0.0% | 1.3% | 4.7% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Economy now FRED unemployment 5.1% in Sep 2026 (4.2% a year earlier); per capita personal income $102,307 in 2025, up 33% in five years (+7.1% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Danielson, CT.
Comments